GSK Trial Raises Regulatory Questions

The Federation of Health Professionals of Argentina (Fesprosa) has called for an investigation by the country's pharmaceutical regulator ANMAT into an ongoing phase IIIb clinical trial of UK-based

To read the full article, please choose one of the following options: